A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

Completed · Phase 2 · Has a placebo group

Conditions studied: Irritable Bowel Syndrome

In brief

The primary purpose of this study is to evaluate the effects of BMS-562086 on small bowel and colonic transits in female subjects with diarrhea-predominant irritable bowel syndrome (D-IBS)

Key facts

Study ID

NCT00399438

Run by

Bristol-Myers Squibb

People needed

39

Starts

2006-12-01

Expected to finish

2008-01-01

Last updated by the study team

2008-09-26

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female subjects with D-IBS symptoms based on Rome II criteria and the subject's responses to the Bowel Disease Questionnaire

You may not qualify if…

• Clinically significant prolonged diarrhea with dehydration requiring IV fluid within 60 days prior to baseline visit

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.